A simulated, randomized study on the safety and immunogenicity of three consecutive commercial-scale batches of the CTN-1V strain human rabies vaccine to verify the inter-batch consistency

• मुख्य लेखकों: Lei Zhou (लेखक), Jingjing Liu (लेखक), Jia Li (लेखक), Xuecheng Liu (लेखक), Jingwu Zhang (लेखक), Fei Nie (लेखक), Jianmin Chen (लेखक), Jing Chai (लेखक), Jinchao Lv (लेखक), Minghui Wang (लेखक), Jiajie Yu (लेखक), Wenjie Wu (लेखक), Yuhua Li (लेखक), Yuhui Zhang (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

In this study, we sought to evaluate the inter-batch consistency and safety of the CTN-1 V human rabies vaccine (Vero cells). A total of 594 healthy participants aged 10-60 years were enrolled from Mianzhu, Sichuan Province, and randomized into three batch groups to receive vaccination via the Essen...